These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 38380073)

  • 1. Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value.
    Igder S; Zamani M; Fakher S; Siri M; Ashktorab H; Azarpira N; Mokarram P
    Dis Markers; 2024; 2024():9943412. PubMed ID: 38380073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Technologies towards Diagnostic and Therapeutic Applications of Circulating Nucleic Acids in Colorectal Cancers.
    Chung J; Xiao S; Gao Y; Soung YH
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update.
    Molnár B; Galamb O; Kalmár A; Barták BK; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Dank M
    Expert Rev Mol Diagn; 2019 Jun; 19(6):477-498. PubMed ID: 31046485
    [No Abstract]   [Full Text] [Related]  

  • 5. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
    Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
    J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
    Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
    J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor Cells and Cell-free Nucleic Acids as Biomarkers in Colorectal Cancer.
    Pourali G; Khalili-Tanha G; Nazari E; Maftooh M; Nassiri M; Hassanian SM; Mobarhan MG; Khazaei M; Ferns G; Avan A
    Curr Pharm Des; 2023; 29(10):748-765. PubMed ID: 36892023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy in colorectal cancer: Onward and upward.
    Torresan S; de Scordilli M; Bortolot M; Di Nardo P; Foltran L; Fumagalli A; Guardascione M; Ongaro E; Puglisi F
    Crit Rev Oncol Hematol; 2024 Feb; 194():104242. PubMed ID: 38128627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylome profiling identifies TCHH methylation in CfDNA as a noninvasive marker of liver metastasis in colorectal cancer.
    Chen S; Liu T; Bu D; Zhu J; Wang X; Pan Y; Liu Y; Lu ZJ; Wang P
    FASEB J; 2021 Jul; 35(7):e21720. PubMed ID: 34110642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis.
    Tóth K; Barták BK; Tulassay Z; Molnár B
    Expert Rev Mol Diagn; 2016; 16(2):239-52. PubMed ID: 26652067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
    Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
    Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer.
    Luo H; Zhao Q; Wei W; Zheng L; Yi S; Li G; Wang W; Sheng H; Pu H; Mo H; Zuo Z; Liu Z; Li C; Xie C; Zeng Z; Li W; Hao X; Liu Y; Cao S; Liu W; Gibson S; Zhang K; Xu G; Xu RH
    Sci Transl Med; 2020 Jan; 12(524):. PubMed ID: 31894106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection.
    Fang Q; Yuan Z; Hu H; Zhang W; Wang G; Wang X
    Clin Epigenetics; 2023 Jul; 15(1):119. PubMed ID: 37501075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the Role of Circulating Cell-Free RNA in the Development of Colorectal Cancer.
    Kan CM; Pei XM; Yeung MHY; Jin N; Ng SSM; Tsang HF; Cho WCS; Yim AK; Yu AC; Wong SCC
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer.
    Wu X; Zhang Y; Hu T; He X; Zou Y; Deng Q; Ke J; Lian L; He X; Zhao D; Cai X; Chen Z; Wu X; Fan JB; Gao F; Lan P
    Mol Oncol; 2021 Oct; 15(10):2702-2714. PubMed ID: 33694305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Circulating Cell-Free DNA to Guide Precision Medicine in Patients with Colorectal Cancer.
    Morris VK; Strickler JH
    Annu Rev Med; 2021 Jan; 72():399-413. PubMed ID: 33502901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
    Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
    Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review.
    Song D; Wang F; Ju Y; He Q; Sun T; Deng W; Ding R; Zhang C; Xu Q; Qi C; Bao J
    Int J Surg; 2023 Apr; 109(4):925-935. PubMed ID: 36974713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
    Ponomaryova AA; Rykova EY; Solovyova AI; Tarasova AS; Kostromitsky DN; Dobrodeev AY; Afanasiev SA; Cherdyntseva NV
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.
    Xie W; Xie L; Song X
    Cancer Med; 2019 Mar; 8(3):1218-1231. PubMed ID: 30791218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.